Health of Adult Assessment 2022

Running Head: Health of Adult
Health of Adult
Name of the student:
Name of the University:
Author’s Note:

1Health of Adult
Table of Contents
Introduction..........................................................................................................................3
Primary admission diagnosis...............................................................................................3
Pathophysiology of cardiovascular disease.........................................................................4
Nursing problem..................................................................................................................5
Role of the Registered nurses in CVD (Cardio Vascular Disease).....................................6
Preventive care by the nurse should be performed as per the evidence-based guidelines to prevent CVD
.............................................................................................................................................6
Pharmacology of cardiovascular disease.............................................................................7
Discharge planning..............................................................................................................8
Conclusion...........................................................................................................................9
References..........................................................................................................................11

2Health of Adult
Introduction
This assessment is on an adult patient who is suffering from cardiovascular disease. The age of the
patient is 45 years and was admitted to the hospital emergency for feeling intense pressure on his heart.
This patient is male in gender and is looked after by me. This report is based on nursing care and
cardiovascular event linking to the pathophysiology and pharmacology of the patient. The
cardiovascular disease is carried by the genetic disorder which accelerates the manifestation of the
disease. The majority of cardiovascular disease risk factors include hypertension, obesity, valvular
disease, and diabetes. This process affects myocardium biology and calls death. This study has been
framed to understand the pathophysiology of the coronary disease of the patient with coronary artery
disease, myocardium infarction (heart failure or heart attacks) with useful pharmacology therapy. The
information relevant to nursing care is the key to plan patient care. This assessment is focused on the
new founded treatments with the identification of the risk related genetic variation and new curative
strategies for cardiovascular disease.

3Health of Adult
Primary admission diagnosis
Cardiovascular disease is the responsible cause of death in Australia. The patient was experiencing chest
pain with dizziness, shortness of breath, as well as a slow heartbeat. After performing various tests, the
patient was admitted to the hospital. The primary diagnosis was coronary angiogram test, which helped
to diagnose the patient who was on the spur of the moment of the heart attacks or in the state after the
heart attacks. The Coronary Computed Tomography Angiogram had been done to identify if the patient
was going under unusual cardiac symptoms (Liaw et al., 2017). The blood test and the blood pressure
monitoring were done to him. The blood pressure measurement was a day to day activity and even in the
state of sleep. Chest X-ray and echocardiogram and electrocardiogram performed before the admission.
Pathophysiology of cardiovascular disease
The previous medical history of the patient and the pathophysiology of the disease is related to the risk
factors. Coronary artery disease is the symptom of atherosclerosis in the coronary arteries. These are the
vessels that supply the myocardium oxygen (Salmond and Echevarria, 2017). Coronary artery disease
includes chest pain, myocardial infarction. Atherosclerosis is a systematic pathophysiology that causes
coronary artery disease (CAD). The CAD has a hereditary fact and genetic influence on the condition.
The identification of the genetic variants from a decade was unsuccessful until the innovation of the
arrays for the low cost genotyping of the patient genomic markers with meta-analyses of multiple cases
identifies the genetic variation related to the CAD (Kieft et al., 2017).
In genome-wide association studies(GWAS), the variants have been found which is associated with the
risks of the disease. The report is focused on the variations of the genes and molecular structure to
understand the pathophysiology of the CAD with the hope for the better treatment of the disease.
According to a study, GWAS identified a locus on chromosome 9p21, which is associated with the